MedDataX Logo

Observational Study to Evaluate the Correctness of the Use of Inhaler Device in Patients With Asthma or Chronic Obstruct

NCT ID: NCT01426893

Last Updated: 2012-03-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

310 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-10-31

Study Completion Date

2012-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The correct use of inhalation devices is an inclusion criterion for all studies comparing inhaled treatments. In real life, however, patients may make many errors with their usual inhalation device, which may negate the benefits observed in clinical trials. In real life, many errors seem to be made, but no wide-scale evaluation has been performed. The correct use of inhalation devices is essential to ensure the effectiveness of the treatment. It has been recently demonstrated that inhaler misuse is associated with decreased asthma control in asthmatics treated with an inhaled corticosteroid. The aim of our observational study was to evaluate the inhaler device usage in patients with asthma or chronic obstructive pulmonary disease (COPD).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Characteristics of Pts Initiating Spiriva Respimat in Asthma

NCT03692676

Asthma
COMPLETED

Prospective evAluatIon foR Inhalation Devices Study

NCT01800994

Asthma COPD
COMPLETED

Non-interventional Retrospective Multicenter Study of Patients With Bronchial Asthma During a Routine Visit to Out of Patients' Clinics

NCT01273363

Asthma
COMPLETED

Asthma in Children

NCT01286532

Asthma
COMPLETED

Cross-sectional Study for Identification and Description of Severe Asthma Patients

NCT02293265

Asthma
COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Observational study to evaluate the correctness of the use of inhaler device in patients with asthma or chronic obstruct

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma, Chronic Obstructive Pulmonary Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

The inhaler device usage in patients with asthma or COPD

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Provision of subject informed consent
* Females or males aged \> 18 years

Exclusion Criteria

\- If participating in any other clinical trial, the subject cannot take part in this study
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AstraZeneca

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Predrag Rebic, Prof.dr

Role: PRINCIPAL_INVESTIGATOR

Clinical Center of Serbia, Belgrade

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Research Site

Belgrade, , Serbia

Site Status

Research Site

Kamenitz, , Serbia

Site Status

Research Site

Kragujevac, , Serbia

Site Status

Research Site

Niš, , Serbia

Site Status

Research Site

Sombor, , Serbia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Serbia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NIS-RRS-XXX-2011/1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effect of High Dose Ciclesonide on Asthma Control
NCT01455194 COMPLETED PHASE3
Evaluating the Symbicort Turbuhaler (Formoterol/Budesonide) Maintenance and Reliever Therapy for Asthma in Daily Practice
NCT00782314 COMPLETED
Safety and Efficacy Study of OC000459 Dosed Twice Daily for 28 Days in Asthmatic Subjects
NCT01057927 COMPLETED PHASE2
Characterisation of Patients With Severe Asthma in Primary and Secondary Care Settings in Europe Reported to be Eligible for Biological Therapy
NCT03629782 COMPLETED
The Use of Inflammatory Markers to Guide Therapy in Children With Severe Asthma
NCT00262340 COMPLETED NA
A Pragmatic Trial of Corticosteroid Optimisation in Severe Asthma
NCT02717689 COMPLETED NA
A Study of Inhaler Use in the Community
NCT02552472 COMPLETED
Longitudinal Observational Study of Severe Asthma
NCT01780142 RECRUITING
Electronic Monitoring of Medication Adherence in Moderate to Severe Asthma Patients
NCT02913092 COMPLETED NA
To Study Device Attributes by Investigating Errors Made in Use, Ease of Use and Preference Among Different Inhalers in Subjects With Asthma
NCT02195284 COMPLETED PHASE4
Characteristics of Type 2- High Inflammatory Endotype of Asthma Using New Biomarkers From Peripheral Blood and Exhaled Air and Its Effect on the Outcome of Therapy
NCT05270278 COMPLETED
Intense Airway Eosinophilia in Asthma
NCT03696914 COMPLETED
Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers
NCT02537691 COMPLETED PHASE4
FeNO After Hypoxia in Asthma Patients
NCT02391090 COMPLETED NA
Comparative Study of the Efficacy of Biologics vs Usual Treatment on OCS Reduction for Severe Asthma Patients Using Health Insurance Claim Database
NCT05136547 COMPLETED
A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of AZD5069 in Patients With Uncontrolled Persistent Asthma.
NCT01704495 COMPLETED PHASE2
Intervention to Improve Inhalative Adherence
NCT02386722 COMPLETED NA
Monitoring Asthma Treatment Using Exhaled Nitric Oxide
NCT00562991 COMPLETED
Clinical& Demographic Profiles of patIents With unControllEd Asthma in Russia: Multi-center oBsErvational ReGistry Study
NCT06521229 RECRUITING
Launching an Asthma Initiative Designed to Improve Asthma Management and Outcomes
NCT02140671 UNKNOWN
Inhaler Adherence in Severe Unstable Asthma
NCT02307669 UNKNOWN NA
Outcome Study Following Reimbursement Changes in the Use of Fixed Combination Inhalers in Patients With Asthma or Chronic Obstructive Pulmonary Disease
NCT01369810 COMPLETED
Inhaler Adherence and Inhalation Technique Assessed by a Smart Spacer in Patients with Severe Asthma on Biologics
NCT06360393 RECRUITING
Pharmacokinetic Comparability of Benralizumab Using Accessorized Pre-Filled Syringe or Autoinjector in Healthy Volunteers
NCT02968914 COMPLETED PHASE1
Asthma Biomarker Study
NCT02392481 COMPLETED